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SELECTIVE ENVIRONMENTALLY BENIGN SYNTHESIS OF ISOTOPE LABELED 
COMPOUNDS: INTRODUCTION OF DEUTERIUM INTO COMPOUNDS OF MEDICINAL 
RELEVANCE 
 
Anne Kokel, Dora Kadish, Béla Török 
Department of Chemistry, University of Massachusetts Boston 
 
Deuterium (2H) is a less abundant isotope of hydrogen that possesses an additional neutron 
resulting in significant differences in the properties of a 1H-containing-molecule compared to its 
2H homologues. Deuterium labeled organic compounds are valuable in medicinal chemistry as 
they offer widespread applications. For instance, in imaging deuteratium labeling can serve as 
biological tracers, thus, deuterated drugs can provide better understanding of the metabolic 
pathways; they can also help localize the metabolites of the drug and assess their toxicity. While 
metabolic enzymes easily transform drug molecules to metabolites that the body can excrete, 
the introduction of deuterium to drugs appears to strengthen the resistance of drugs toward 
metabolism. In fact, the carbon-deuterium bond is known to be six to ten times stronger than its 
C-1H counterpart. The higher the stability, the longer the drug remains intact, which allows lower 
dosage, potentially causing fewer side effects. Due to the carbon-deuterium bond strength, 
deuterated drugs can also prevent the formation of toxic metabolites observed with its 
hydrogen-containing homologue.  
 
There are several known methods for the introduction of deuterium to organic compounds; most 
methods, however, do not conform to the recent expectations and standards of sustainable 
synthesis. Therefore, a green synthesis of deuterated organic compounds would be an 
important advance in producing these compounds in an environmentally sustainable way. Thus, 
we have turned our attention to the Al-H2O system that is commonly applied for hydrogenation 
reactions. Replacing the H2O with its deuterated version D2O in the system constitutes an easy, 
economic and safe source of deuterium. The application of either the commercially available Ni-
Al alloy or Al in combination with Pd, a common hydrogenation catalyst, for the H-D exchange of 
compounds with reactive C-H bonds was performed, while yielding no harmful byproducts. The 
low reactivity of the aluminum metal was significantly enhanced by the application of ultrasonic 
irradiation prior to the reaction. The H-D exchange reaction was carried out under microwave 
irradiation and achieved good yields in no more than 1h. The success of the method was 
demonstrated by applying a broad variety of compounds from essential amino acids to actual 
drug compounds. 
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